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Abstract: Enaminones 3 and 4, precursors of 4-thiazolidinones, were  prepared by condensing tetronic acid (1a) 
and 4-hydroxy 6-methyl pyrone (1b) respectively with thiosemicarbazide derivatives 2 in refluxing ethanol.  The 
4-thiazolidinones 6, 7 derivatives were obtained by reacting compounds 3 or 4 with ethyl 2- bromo propionate 5 
in the presence of anhydrous sodium acetate in ethalonic medium. Similarly, 9 products were synthesized by 
action of benzyl 2-bromo acetate 8 on 3. 
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1. Introduction 
 
The structures of 4-thiazolidinones and 4-imino thiazolidinones are widely studied for their 
pharmacological  properties.
1-2  The  4-thiazolidinone  derivatives  are  known  to  possess  anti-
mycobacterial
3-4,  anti-fungal
5,  anti-tuberculosis
3,6-7,  anti-convulsant
8,  anti-inflammatory
9-11  and  anti-
HIV
12-14  activities.  Various  synthetic  approaches  of  these  molecules
  were  reported.
2,3,9,11,12,15-20  
Nevertheless  a  common synthetic  strategy to construct  imino thiazolidinones  is the  cyclization of 
thiourea  or  thiosemicarbazide  derivatives  with  α-halo  esters  or  thioglycolic  acids  in  presence  of 
inorganic  base  (i.e.,  NaOAc)  in  polar  solvents  using  either  a  conventional
  3,11-16  or  microwave 
irradiation methods.
21-23 
In this paper, we are interested in the construction of this heterocylic ring system from tetronic 
acid (n=0, 1a) and 4-hydroxy 6-methyl 2-one-pyran (n=1, 1b) with thiosemicarbazide derivatives 2 
which give enaminones 3 and 4 respectively. These reacted with 2-bromo propionate 5 or benzyl 2-
bromo acetate 8 leading to 4-thiazolidinones 6, 7 and  9 respectively. 
                                                
* Corresponding author: Email-address: bellara_kollidz@yahoo.fr 
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Scheme 1 summarizes the chemical strategy used for the preparation of these compounds.   
 
2. Results and Discussion 
 
The synthesis of enaminolactones 3, 4 was carried out, in good yields as previously reported
24, 
by  reacting  a  suitable  tetronic  acid  (1a)  or  4-hydroxy-6-methyl  pyrane  (1b)  with  an  appropriate 
substituted thiosemicarbazide 2 in ethanol at reflux.  
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Scheme 1. Synthesis of  4-thiazolidinone structures. 
 
Reaction of intermediates 3 and 4 with ethyl 2- bromo propionate 5 or benzyl 2-bromo acetate 
8 as cyclising reagents, in boiling absolute  ethanol containing 3 equimolars of anhydrous  sodium 
acetate and acetic acid as catalyst, afforded the 4- thiazolidinones 6, 7 and 9 which were purified on 
chromatography column (Scheme 1; Table 1). 
 
Enaminolactone thiosemicarbazid group 3 and 4 contains four nucleophilic centers, i.e. Na, Nb, 
Nc and the sulphur atom. Cyclisation possibilities of compounds 3 or 4 with ethyl 2- bromo propionate  
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5 could be achieved either by: nitrogen Na with sulphur (path way 1) or Nb with sulphur (path way 2) 
or Nc with sulphur (path way 3) to lead to 6, 7 and 10 or 11 structure respectively. It should be noted 
that cyclisation reaction of 3 or 4 with ethyl 2- bromo propionate 5 to 10 would not promote due to the 
Na free-double bound engaged in a conjugated ring system
2, that makes this atom less nucleophilic in 
comparison with Nb and Nc atoms. 
In the used operating conditions, sodium acetate captures the nitrogen proton Nb and results in 
thiol form
2, allowing the interaction type Soft-Soft
 between sulphur atom and the electrophile center 
(CH-Br) according to Pearson’s HSAB ( Hard and Soft acids and bases) rules
25-26. The interaction 
Hard-Hard of nitrogen Nc with the carbonyl function leads to 4- thiazolidinones 6, 7 and excluses the 
formation of structures 11. 
Therefore, the cyclization reaction might be summarised in two steps: 
First, the reaction is thought to be an S-alkylation of compounds 3 and 4 in its thiol form (due to the 
sodium acetate used). 
The  second  step  involves  the  ethanol  removal  and  regeneration  of  acetic  acid  to  give  4-
thiazolidinones. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2. Mechanism reaction of 4-thiazolidinones 6 and 7 from enaminolactones and ethyl 
2- bromo propionate 
 
 
Compounds 9 were obtained with a similar reaction mechanism using benzyl 2-bromo acetate 8 as 
reagent. Both analytical and spectral data of all the synthesized compounds are in full agreement with 
the formation of 4-thiazolidinones structures 6 and 7. 
The IR spectra of 4- thiazolidinones 6, 7 and 9 gave lactam (C=O) stretching bands of the 
thiazolidinones ring at 1700-1705 cm
-1 in addition to the bands stretching (C=O) at 1651 and 1650 cm
-
1 of enaminolactones. 
The 
1H-NMR spectra of these 4-thiazolidinone derivatives, reveal the absence of NC-H and 
Nb-H of enaminolactones 3 or 4 commonly observed at 9-10 ppm and the presence of two new signals 
at 1.52 ppm as a doublet (J= 9 Hz) and 4.50 ppm as a quadruplet (J=9Hz) attributed respectively to the 
methyl group -CH3 and SCHCO proton of thiazolidinone moiety in structures 6 and 7. On the other 
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hand, peaks at 19, 158 and 176 ppm in the 
13C-NMR spectrum of structures 6a-c and 7a-c are assigned 
to the methyl group -CH3, the imine C=N and carbonyl C=O functions respectively. 
In conclusion, a series of 4-thiazolidinones 6, 7 were synthesized from enaminolactones 3 or 4 
and ethyl  2-  bromo  propionate  5  in  the  presence of anhydrous  sodium acetate and  acetic  acid in 
refluxing absolute ethanol. Similarly, these enaminolactones react with benzyl 2-bromo acetate 8 to 
lead  9  derivatives.  The  reaction  mechanism  of  these  molecules  shows  a  regiospecific  cyclisation, 
involving the Nc  nitrogen and the sulphur atom. 
 
3. Experimental 
 
(Melting points were measured on a Buchi 512 apparatus and were uncorrected. FTIR were 
taken in Nujol on a Perkin –Elmer spectrometer. The 
1H NMR spectra (250 MHz) and 
13C NMR (63 
MHz) were run on a Bruker spectrometer in DMSO- d6 or CDCl3 using tetramethyl silane as internal 
standard. The impact ionisation  (IE) mass spectra were recorded on a Nermag R-10-10C at 70 ev. The 
elemental  analysis  data  were  performed  on  a  Thermo  Electron  Flash  EA  1112.  Chemicals  were 
purchased from Aldrich and Fluka. 
The preparation of enamine derivatives 3 and 4 were previously described by us.
24   
 
3.1. General procedure for the formation of 4-thiazolidinones 6a-c and 7a-c. 
 
10 mL of appropriate thiosemicarbazide 3 or 4 and 12 mL of ethyl bromo propionate 5 were 
refluxed in 30 mL for 8-9 hours of absolute ethanol in the presence of 4 mL of anhydrous sodium 
acetate and 10 drops of acetic acid. 
The reaction mixture was cooled and concentrated under reduced pressure. Then, 30 mL of water was 
added to the residue and was extracted with 40 mL of ethyl acetate. The organic phase was dried over 
anhydrous Na2SO4. The product was isolated and separated on chromatography column employing 
different eluants (7a-c: CH2Cl2/ ethyl acetate (7:3); 6a: petroleum ether / CH2Cl2 (5:1); 6b: CH2Cl2/ 
ethyl acetate (9:1); 6c: ethyl acetate). 
Py: pyrone; Th: thiazolidinone. 
 
5-methyl-1,3-thiazolidine-2,4-dione 2-[(5-oxo-2,5-dihydrofuran-3-yl)hydrazone] (6a):  
Yield: 30 %; yellow crystal; m.p. 110-112 
oC. IR (Nujol, cm
-1) 1650 (C=Opyr), 1701 (C=0Th); 
1H 
NMR (250 MHz, DMSO- d6) (δ/ppm): 1.52 (d, 3H, Th, CH3 J= 9 Hz), 4.33 (q, 1H, Th, CH, J=9Hz), 
4.67 (s, 1H, py =CH), 4.74 (s, 2H, py CH2), 9.78 (s, 1H, NHa), 11.72 (s, 1H, NH); 
13C NMR (63 MHz, 
DMSO- d6) (δ/ppm): 19.78 (CH3), 45.13 (CH), 67.16 (CH2), 81.93 (=CH), 158.61 (N=C), 167.06 
(NC=), 175.05 (OC=O), 176.30 (NC=O). MS. (IE, 70eV): m/z  227([M+.], 22%), 183(33), 129(60), 
100(15), 85(100), 83(23). Anal. Calcd. for C8H9N3O3S: C, 42.28;  H, 3.99, N, 18.49; O, 21.12; S, 
14.11. Found: C, 42.40;  H, 3.85,  N, 18.30. 
 
3,5-dimethyl-1,3-thiazolidine-2,4-dione 2-[(5-oxo-2,5-dihydrofuran-3-yl)hydrazone] (6b): 
Yield: 68 %; Yellow crystal; m.p. 200-202 
oC. IR (Nujol, cm
-1) 1651 (C=Opyr), 1702 (C=0Th); 
1H 
NMR (250 MHz, DMSO- d6) (δ/ppm): 1.55 (d, 3H, Th, CH3, J= 9 Hz), 3.06 (s, 3H, NCH3), 4.38 (q, 
1H, Th, CH, J=9Hz), 4.79 (s, 1H, py =CH), 4.81 (s, 2H, py CH2), 10.17 (s, 1H, NHa); 
13C NMR (63 
MHz, DMSO- d6) (δ/ppm): 19.75 (CH3), 31.25 (CH3), 45.16 (CH), 67.20 (CH2), 81.95 (=CH), 158.63 
(N=C),  167.10  (NC=),  175.07  (OC=O),  176.35  (NC=O).  S.M  (IE,  70eV):  m/z  241([M+.],  18%), 
143(31), 197(79), 104(35), 99(10), 83(100). Anal. Calcd. for C9H11N3O3S: C, 44.80; H, 4.60; N,17.42; 
O, 19.89; S,13.29. Found: C, 44.60; H, 4.80; N, 17.40. 
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5-methyl-3-phenyl-1,3-thiazolidine-2,4-dione-2-[(5-oxo-2,5-dihydrofuran-3-yl)  
hydrazone] (6c): Yield: 33 %; Yellow crystal; m.p. 220-222 
oC. IR (Nujol, cm
-1) 1650 (C=Opyr), 
1700 (C=0Th); 
1H NMR (250 MHz, DMSO- d6) (δ/ppm):1.66 (d, 3H, Th, CH3, J= 9 Hz), 4.48 (q, 1H, 
Th, CH, J=9Hz), 4.58 (s, 1H, py =CH), 4.63 (s, 2H, py CH2), 7.34-7.51 (m, 5Haro), 10.18 (s, 1H, NHa); 
13C  NMR  (63  MHz,  DMSO-  d6)  (δ/ppm):  19.87  (CH3),  44.11  (CH),  67.02  (CH2),  82.45  (=CH), 
129.07, 129.52, 129.81, 135.71 (Caro), 158.61 (N=C), 167.13 (NC=), 174.33 (OC=O), 174.85 (NC=O). 
S.M (IE, 70eV): m/z 303 ([M+.], 7%), 205(100), 129(34), 100(5), 85(81), 83(10). Anal. Calcd. for 
C14H13N3O3S: C, 55.43; H, 4.32; N, 13.85; O, 15.82; S, 10.57. Found: C, 55.60; H, 4.28; N, 13.97. 
 
5-methyl-1,3-thiazolidine-2,4-dione-2-[(2-methyl-6-oxo-3,6-dihydro-2H-pyran-4-yl) 
hydrazone] (7a): Yield: 34 %; Yellow crystal; m.p. 195-197 
oC. IR (Nujol, cm
-1) 1650 (C=Opyr), 
1702 (C=0Th); 
1H NMR (250 MHz, DMSO- d6) (δ/ppm): 1.44 (d, 3H, py, CH3 J= 8 Hz), 1.65 (d, 3H, 
Th, CH3, J= 9 Hz), 2.58-2.85, (m, 2H, py CH2), 4.26 (m, 1H, py CH), 4.52 (q, 1H, Th, CH, J=9Hz), 
4.88 (s, 1H, py =CH), 9.50 (s, l, 1H, NHa), 11.92 (s, 1H, NH); 
13C NMR (63 MHz, DMSO- d6) 
(δ/ppm): 19.14 (CH3), 20.78 (CH3), 31.84 (CH2), 44.29 (CH), 71.80 (CH), 83.35 (=CH), 158.0 (N=C), 
167.24 (NC=), 176.17 (OC=O), 177.10 (NC=O). S.M (IE, 70eV): m/z 255([M+.], 14%), 211(40), 
131(100),  112(55),  102(23),  87(24).  Anal.  Calcd.  for  C10H13N3O3S:  C,  47.05;  H,5.13;  N,16.46  ; 
O,18.80; S, 12.56. Found: C, 42.50;  H, 3.91, N, 18.32. 
 
3,5-dimethyl-1,3-thiazolidine-2,4-dione-2-[(2-methyl-6-oxo-3,6-dihydro-2H-pyran-4-
yl)hydrazone] (7b): Yield: 30 %; Light brown oil; IR (Nujol, cm
-1) 1650 (C=Opyr), 1702 (C=0Th); 
1H NMR (250 MHz, CDCl3) (δ/ppm): 1.45 (d, 3H, py, CH3 J= 8 Hz), 1.62 (d, 3H, Th, CH3, J= 9 Hz), 
2.50-2.65, (m, 2H, py CH2), 3.44 (s, 3H, NCH3), 4.19 (m, 1H, py CH), 4.55 (q, 1H, Th, CH, J=9Hz), 
4.64 (s, 1H, py =CH), 9.65 (s, l, 1H, NHa); 
13C NMR (63 MHz, CDCl3) (δ/ppm): 19.49 (CH3), 20.88 
(CH3), 30.16 (NCH3), 34.69 (CH2), 45.94 (CH), 73.08 (CH), 83.35 (=CH), 158.42 (N=C), 169.11 
(NC=),  175.60 (OC=O), 176.69 (NC=O). S.M (IE, 70eV): m/z 269([M+.], 30%), 145(25), 116(70), 
112(100), 101(54), 87(5). Anal. Calcd. for C11H15N3O3S: C, 49.06;  H, 5.61; N,15.60; O, 17.82; S, 
11.91. Found: C, 49.25;  H, 5.70; N,15.43. 
 
5-methyl-3-phenyl-1,3-thiazolidine-2,4-dione-2-[(2-methyl-6-oxo-3,6-dihydro-2H-pyran-
4-yl)  hydrazone]  (7c): Yield:  32  %;  Yellow  crystal;  m.p.  276-278 
oC.  IR  (Nujol,  cm
-1)  1652 
(C=Opyr), 1705 (C=0Th); 
1H NMR (250 MHz, DMSO- d6) (δ/ppm): 1.31 (d, 3H, py, CH3 J= 8 Hz), 1.56 
(d, 3H, Th, CH3, J= 9 Hz), 2.50 (m, 2H, py CH2), 4.58 (m, 1H, py CH), 4.76 (q, 1H, Th, CH, J=9Hz), 
4.86 (s, 1H, py =CH), 6.90-7.38 (5H, CHar); 9.78 (s, l, 1H, NHa); 
13C NMR (63 MHz, DMSO- d6) 
(δ/ppm):  19.53  (CH3),  21.46  (CH3),  32.54  (CH2),  45.04(CH),  72.28  (CH),  83.26  (=CH),  129.01-
129.24-129.35-134.40 (Caro), 158.79 (N=C), 168.24 (NC=),   176.97 (OC=O), 177.88 (NC=O). S.M 
(IE,  70eV):  m/z  331([M+.],  30%),  207(25),  178(100),  163(44),  112(54),  87(7).  Anal.  Calcd.  for 
C16H17N3O3S: C, 57.99; H, 5.17; N, 12.68; O,14.48; S, 9.68. Found: C, 58.01; H, 5.19; N, 12.60. 
 
3.2. Synthesis of 4-thiazolidinones compounds 9a-b. 
 
A (10 mL) suspension of enaminolactones 3a-b and 12 mL of benzyl 2-bromo acetate 8 were 
refluxed in 30 mL of absolute ethanol in the presence 4 mL of anhydrous sodium acetate and 10 drops 
of acetic acid for 4 hours. The precipitate obtained was filtered and recrystallized in ethanol. 
 
1,3-thiazolidine-2,4-dione  2-[(2-oxo-2,5-dihydrofuran-3-yl)hydrazone]  (9a): Yield:  30  %; 
White crystal; m.p. 230-232 
oC. IR (Nujol, cm
-1) 1651 (C=Opyr), 1705 (C=0Th); 
1H NMR (250 MHz, 
DMSO- d6) (δ/ppm): 4.02 (s, 2H, Th CH2), 4.67 (s, 1H, py =CH), 4.74 (s, 2H, py CH2), 9.98 (s, 1H, 
NHa), 11.73 (s, 1H, NH); 
13C NMR (63 MHz, DMSO- d6) (δ/ppm): 35.23 (CH2), 67.16 (CH2),  81.90 
(=CH),  158.60  (N=C),  167.09(NC=),  173.49  (OC=O),  175.06  (NC=O).  S.M  (IE,  70eV):  m/z 
213([M+.], 17%), 197(4), 143(100), 117(32), 98(44), 87(12). Anal. Calcd. for C7H7N3O3S: C,39.43; 
H, 3.31; N, 19.71; O, 22.51; S, 15.04. Found: C, 39.50; H, 3.28;  N, 19.68.  
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3-methyl-1,3-thiazolidine-2,4-dione  2-[(2-oxo-2,5-dihydrofuran-3-yl)hydrazone]  (9b):  
Yield: 40 %; White crystal; m.p. 208-210 
oC; IR (Nujol, cm
-1) 1650 (C=Opyr), 1704 (C=0th); 
1H NMR 
(250 MHz, DMSO- d6) (δ/ppm): 3.10 (s, 3H, NCH3), 4.00 (s, 2H, Th, CH2), 4.58 (s, 1H, py =CH), 
4.71 (s, 2H, py CH2), 7.71 (s, 1H, NHa); 
13C NMR (63 MHz, DMSO- d6) (δ/ppm): 23.56 (NCH3), 
33.95  (CH2),  67.53  (CH2),  81.91  (=CH),  158.60  (N=C),  167.10  (NC=),  171.70  (OC=O),  174.06 
(NC=O). S.M (IE, 70eV): m/z 227([M+.], 2%), 111(9), 143(65), 131(44), 98(4), 89(100). Anal. Calcd 
for C8H9N3O3S: C, 42.28; H, 3.99; N, 18.49; O,21.12;  S, 14.11. Found: C, 42.30; H, 3.91; N, 18.51. 
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